Home › Cellular Dynamics Announces Agreement With AstraZeneca On Use Of iPSC-Derived Human Cells In Drug Discovery Research
 

Keywords :   


Cellular Dynamics Announces Agreement With AstraZeneca On Use Of iPSC-Derived Human Cells In Drug Discovery Research

2013-01-07 07:29:27| drugdiscoveryonline Home Page

Cellular Dynamics International, Inc. (CDI) recently announced a Center of Excellence agreement with AstraZeneca to accelerate the pace of drug discovery through the use of human induced pluripotent stem cell (iPSC) lines and tissue cells.

Tags: research agreement human drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
16.11LivreIPEF30/+
16.11Episode41
16.11CDCD
16.11TR3.5 30g 2
16.11
16.11 Fender mij traditional 60s stratcaster
16.11G
16.11WOMEN
More »